Skip to content
AgingNexus
☰ Menu

Evidence brief · hallmark

Dysbiosis

Synthesized from 10 indexed sources · 2026-06-04 MST · preview (no AI key)
Preview synthesis (deterministic, no AI key configured). Set a provider key to generate the full brief.

Synthesis (preview — no live AI key for the active provider):

Across the retrieved literature, senescent-cell burden and chronic inflammation recur as central, interacting drivers, with intervention studies reporting functional gains in model organisms. Key works: [1][2][3][4][5].

Set the active provider's API key to generate full model-written analysis.

Sources

  1. [1] Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
  2. [2] Development of a WHO growth reference for school-aged children and adolescents
  3. [3] Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  4. [4] Human gut microbiome viewed across age and geography
  5. [5] The genetic legacy of the Quaternary ice ages
  6. [6] The amyloid hypothesis of Alzheimer's disease at 25 years
  7. [7] Ranibizumab for Neovascular Age-Related Macular Degeneration
  8. [8] The adolescent brain and age-related behavioral manifestations
  9. [9] The Effects of Sex Hormones on Cognition and Mood in Older Adults
  10. [10] A Randomized, Double-blind, Placebo-controlled Exploratory Clinical Study to Evaluate the Safety and Tolerability of SPOT-mRNA01 Injection in Healthy Adult Subjects.
All Dysbiosis works →